AtmosAir Solutions of Fairfield, Connecticut, a provider of continuous indoor environmental sanitizing technology for health care organizations has announced that its patented bi-polar ionization (BPI) HVAC technology has tested more than 99.9 percent effective in neutralizing coronavirus.
Tests performed by Microchem Laboratory, one of the world’s preeminent laboratories for testing sanitizing products registered by the EPA and FDA, confirmed that the presence of coronavirus was reduced by 99.92 percent within 30 minutes of exposure to AtmosAir’s bi-polar ion technology.
The testing replicated realistic conditions, exposing the virus only to the concentration of ions that would be present in an occupied building. The results prove that AtmosAir’s public health solution, effective in stopping the spread of pathogens and contaminants, directly impacts and neutralizes coronavirus in medical and healthcare facilities.
NYU Langone, Lyndon B. Johnson Hospital, The Walter Reed National Military Medical Center and McLaren Health Care are among the medical facilities using AtmosAir’s BPI technology. A more detailed list is at: atmosair.com/commercial/healthcareprojects.
AtmosAir’s patented BPI devices, which easily fit into new or existing HVAC systems, continually emit ions into the air that seek, attack, and neutralize coronavirus, germs, bacteria, mold and other contaminants. The ions attach to contaminants and neutralize them in the air and on surfaces rendering the contaminants inactive, even if inhaled or ingested.
“We are delivering a cost-effective, environmentally and socially sustainable public health product that can deliver results so that we can start coming together again safely,” said Steve Levine, president and CEO of AtmosAir Solutions. “We’re immensely proud to verify, independently through a leading testing facility, that our technology is effective against the world’s most pressing global health concern right now.”
“This result further validates how beneficial the active continuous disinfection with AtmosAir bi-polar ionization can be to neutralize coronavirus,” said Tony Abate, vice president and chief technical officer at AtmosAir Solutions. “Our patented process saturates the occupied space where people live and breathe with beneficial ions that can attack these contaminants at their source and offer another layer of protection against the spread of illness.”
In addition to medical and health care facilities, AtmosAir’s PBI technology is being used in over 7,500 commercial buildings, hotels, airports, casinos, cruise lines, universities and sports facilities in the United States and globally.
For more information, visit atmosair.com.
*By entering your email address, you agree to receive emails regarding TechNation Magazine, Webinars, and Exclusive Promos.
© 2020, TechNation Magazine. Site designed by MD Publishing, Inc.